by Truveta staff | Mar 11, 2024 | Research
Each year, approximately 900,000 patients in the US are affected by a pulmonary embolism (PE), a blood clot causing a blockage in one or more pulmonary arteries in the lungs. PE is a leading cause of in-hospital death in the US, and acute PE – a sudden blockage...
by Truveta Research | Mar 6, 2024 | Research, Research Insights
Disparities in time to treatment and treatment outcomes exist for people with severe aortic stenosis receiving TAVR and SAVR procedures. We studied the rate of people who receive TAVR, SAVR, aortic valve repair, and aortic balloon valvuloplasty procedures and time to...
by Truveta staff | Feb 29, 2024 | Data, News, Technology
Healthcare data traditionally has been too siloed, inaccessible, and messy to be useful for research. And one of the biggest challenges has been that critical information about a patient’s health is locked away in the unstructured text in clinician notes. Thanks to...
by Truveta staff | Feb 23, 2024 | Research
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout January 2024 (-35.3%) compared to December 2023. The largest decreases were seen in parainfluenza virus- (-49.0%), RSV- (-48.0%), and influenza-associated (-41.6%)...
by Truveta Research | Feb 22, 2024 | Research, Research Insights
Aortic stenosis – the narrowing of the valve between the lower left heart chamber (left ventricle) and the aorta – is commonly diagnosed with an echocardiogram and staged according to the disease progression. However, it’s a difficult condition to study across large...
